According to the organization, the well-being of oral health professionals who provide oral health care and educate future dental professionals is a top priority for ADEA, which believes that the oral health community must continue to set a positive example when it comes to vaccinations.
ADEA's statement comes in the wake of an Executive Order requiring COVID-19 vaccinations for federal employees.
Additionally, a Joint Statement issued by the American Public Health Association and more than four dozen other health care organizations calls for all health care and long-term care employers to require their employees to receive the COVID-19 vaccine.
The Centers for Disease Control and Prevention has more detail on the COVID-19 vaccines and their effectiveness in reducing transmission of the coronavirus.
The American Dental Education Association is The Voice of Dental Education.
Its mission is to lead and support the health professions community in preparing future-ready oral health professionals.
ADEA members include all 78 US and Canadian dental schools, more than 800 allied and advanced dental education programs, more than 50 corporations and approximately 18,000 individuals.
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine